Patients Opt for 3D Simulation for Breast Augmentation – But It Doesn't Improve Outcomes
Three-dimensional image simulation is popular among women planning breast augmentation surgery. But while this evolving technology may enhance communication, it doesn't improve patient satisfaction with the results of the procedure, reports a paper in the August issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
"Patients are likely to use novel technology like three-dimensional photography with computer simulation if they perceive it to enhance their understanding of their final outcome," write ASPS Member Surgeon Terence Myckatyn, MD, and colleagues of Washington University School of Medicine, St. Louis. However, 3D stimulation "did not lead to clinically meaningful changes in patient-reported outcomes." Bo Overschmidt, BSc, and Ali A. Qureshi, MD, were the lead authors of the new report.
3D Simulations Help Patients Visualize Cosmetic Outcomes
The study evaluated the impact of 3D imaging with computer simulation on the outcomes of breast augmentation. In this technique, the plastic surgeon obtains digital photographs, then uses imaging software to create a 3D simulation of how the patient's breasts will look after surgery. The surgeon and patient can adjust different variables, such as cup size and implant volume, to help in procedure planning and decision-making.
The study included 100 women undergoing breast augmentation over a three-year period. Twenty-three women agreed to participate in a randomized trial, where they were randomly assigned to 3D simulation (10 patients) or conventional "tissue-based" planning (13 patients).
But after the first few months, all of the women enrolled in the study opted for 3D simulation – perhaps reflecting increased awareness of this preoperative planning option via the Internet and word of mouth.
The researchers used two approaches to evaluate how 3D simulation affected breast augmentation outcomes. A standard questionnaire called the BREAST-Q© was used to assess patient satisfaction and various domains of quality of life. In addition, a detailed set of "mammometric" measurements was obtained to evaluate objective results.
On the BREAST-Q questionnaire, breast augmentation led to substantial improvements in satisfaction with breasts, sexual well-being, and psychosocial outcomes. However, the use of 3D simulation had no significant effect on any of these patient-reported outcomes, compared to tissue-based planning. In both groups, on a 0-to-100 scale, average score for satisfaction with breasts increased from about 20 before surgery to 85 after surgery.
The mammometric measurements were also similar between groups, with no significant correlations between the patient-reported and mammometric results. There was also no significant difference in the volume of implants chosen by women undergoing 3D simulation versus tissue-based planning.
Previous studies have shown that 3D simulation can facilitate communication and preoperative planning in women undergoing breast augmentation. The new study finds that this technology is popular with patients – almost all of whom choose to undergo 3D simulation, if made aware of its availability. "These patients may seek out practices specifically offering such technology," Dr. Myckatyn and coauthors write.
The researchers discuss some limitations of their study, including the reasons why 3D simulation doesn't necessarily improve patient satisfaction with breast augmentation. They note that many factors may affect patient satisfaction, and that a range of implant sizes and styles may help patients achieve their aesthetic goals.
Dr. Myckatyn and colleagues also point out that, while 3D simulations may provide a useful communication tool, plastic surgeons already achieve excellent cosmetic results using conventional tissue planning techniques. The authors write, "Any potential impact of simulation of postoperative patient satisfaction may have been of insufficient magnitude to move the needle on already high scores."
Click here to read "A Prospective Evaluation of Three-Dimensional Image Simulation: Patient-Reported Outcomes and Mammometrics in Primary Breast Augmentation"
Article: "A Prospective Evaluation of Three-Dimensional Image Simulation: Patient-Reported Outcomes and Mammometrics in Primary Breast Augmentation" (doi: 10.1097/PRS.0000000000004601)
About Plastic and Reconstructive Surgery
For over 75 years, Plastic and Reconstructive Surgery® has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair and cosmetic surgery, as well as news on medico-legal issues.
The American Society of Plastic Surgeons (ASPS) is the largest organization of board-certified plastic surgeons in the world. Representing more than 11,000 physician members worldwide, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 92 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions and services for the clinicians, nurses, accountants, lawyers and tax, finance, audit, risk, compliance and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.